1. Home
  2. LNN vs VOR Comparison

LNN vs VOR Comparison

Compare LNN & VOR Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.

Logo Lindsay Corporation

LNN

Lindsay Corporation

HOLD

Current Price

$109.07

Market Cap

1.2B

Sector

Industrials

ML Signal

HOLD

Logo Vor Biopharma Inc.

VOR

Vor Biopharma Inc.

HOLD

Current Price

$14.80

Market Cap

934.7M

Sector

Health Care

ML Signal

HOLD

Company Overview

Basic Information
Metric
LNN
VOR
Founded
1954
2015
Country
United States
United States
Employees
N/A
N/A
Industry
Industrial Machinery/Components
Biotechnology: Pharmaceutical Preparations
Sector
Industrials
Health Care
Exchange
Nasdaq
Nasdaq
Market Cap
1.2B
934.7M
IPO Year
1995
2021

Fundamental Metrics

Financial Performance
Metric
LNN
VOR
Price
$109.07
$14.80
Analyst Decision
Hold
Buy
Analyst Count
1
10
Target Price
$113.00
$45.33
AVG Volume (30 Days)
153.4K
815.9K
Earning Date
04-02-2026
05-11-2026
Dividend Yield
1.35%
N/A
EPS Growth
12.81
N/A
EPS
2.70
N/A
Revenue
$676,368,000.00
N/A
Revenue This Year
N/A
N/A
Revenue Next Year
$4.74
N/A
P/E Ratio
$40.49
N/A
Revenue Growth
11.41
N/A
52 Week Low
$97.27
$0.17
52 Week High
$149.56
$49.95

Technical Indicators

Market Signals
Indicator
LNN
VOR
Relative Strength Index (RSI) 47.47 47.75
Support Level $106.63 $11.74
Resistance Level $115.75 $16.87
Average True Range (ATR) 3.43 0.97
MACD 0.28 -0.09
Stochastic Oscillator 45.63 21.65

Price Performance

Historical Comparison
LNN
VOR

About LNN Lindsay Corporation

Lindsay Corp provides proprietary water management and road infrastructure products and services. It manufactures and distributes agricultural irrigation equipment through two segments: Irrigation and Infrastructure. The Irrigation segment makes center pivot, lateral move, and hose reel irrigation systems and parts. The Infrastructure segment produces barriers, crash cushions, road marking and safety equipment, and railroad signals. The majority of revenue is from the Irrigation segment. The company operates in the United States and international markets, with the majority of revenue coming from the United States.

About VOR Vor Biopharma Inc.

Vor Biopharma Inc is a clinical-stage biopharmaceutical company focused on developing novel therapies for the treatment of autoimmune diseases. Its program, telitacicept, is a potential first- and best-in-class dual BAFF/APRIL inhibitor designed to suppress the signaling pathways that drive the maturation, proliferation, and survival of harmful B cells, including self-reactive B cells, thereby reducing autoantibody production and preventing downstream tissue damage.

Share on Social Networks: